Title: Production of Alpha Emitters for Targeted Alpha Therapy
Authors: MORGENSTERN AlfredABBAS KamelBRUCHERTSEIFER FrankAPOSTOLIDIS Christos
Citation: CURRENT RADIOPHARMACEUTICALS vol. 1 no. 3 p. 135-143
Publisher: BENTHAM SCIENCE PUBL LTD
Publication Year: 2008
JRC N°: JRC48527
ISSN: 1874-4710
URI: http://www.bentham.org/crp/contabs/crp%201-3.htm#3
http://publications.jrc.ec.europa.eu/repository/handle/JRC48527
Type: Articles in Journals
Abstract: Targeted alpha therapy (TAT) is a promising approach for the treatment of cancer and infectious diseases. The availability of suitable alpha emitting isotopes in clinically relevant amounts is a main prerequisite for further development of TAT and its widespread clinical application. Several alpha emitting isotopes have been proven effective in pre-clinical studies and/or clinical trials, including 225Ac / 213Bi, 230U / 226Th, 227Th / 223Ra, 212Pb / 212Bi, 211At and 149Tb. Here we give an overview on methods for the production of these nuclides, describe advantages and limitations of the various processes and give an outlook on future availability and isotope supply.
JRC Institute:Institute for Transuranium Elements

Files in This Item:
There are no files associated with this item.


Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.